Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Perifolliculitis Capitis Abscedens et Suffodiens Treated with Anti-tumor Necrosis Factor-alpha- Possible New Treatment Option (CROSBI ID 255182)

Prilog u časopisu | ostalo | međunarodna recenzija

Sjerobabski Masnec, Ines ; Franceshi, Nika Perifolliculitis Capitis Abscedens et Suffodiens Treated with Anti-tumor Necrosis Factor-alpha- Possible New Treatment Option // Acta Dermatovenerologica Croatica, 26 (2018), 3; 255-259

Podaci o odgovornosti

Sjerobabski Masnec, Ines ; Franceshi, Nika

engleski

Perifolliculitis Capitis Abscedens et Suffodiens Treated with Anti-tumor Necrosis Factor-alpha- Possible New Treatment Option

We present the case of a 26-year-old male patient with perifolliculitis capitis abscedens et suffodiens (PCAS) who later developed hidradenitis suppurativa (HS) and exacerbation of acne. The patient did not respond well to conventional treatment including isotretinoin and oral antibiotics. Quality of life was significantly impaired. After introduction of anti-tumor necrosis factor-alpha (TNF-ɑ) treatment, the patient’s clinical picture improved dramatically and quality of life increased. The treatment has been well tolerated by the patient for 15 months at time of writing

perifolliculitis capitis abscedens et suffodiens, hidradenitis suppurativa, anti tumor necrosis factor-alpha

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

26 (3)

2018.

255-259

objavljeno

1330-027X

1847-6538

Povezanost rada

nije evidentirano

Indeksiranost